Literature DB >> 15655754

A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis.

Wen-Chien Ko1, Jing-Joung Yan, Wen-Liang Yu, Hsin-Chun Lee, Nan-Yao Lee, Li-Rong Wang, Yin-Ching Chuang.   

Abstract

Recently, antimicrobial resistance among nontyphoid Salmonella serotypes has been increasingly recognized. In southern Taiwan, we encountered 3 cases of invasive infections caused by Salmonella enterica serotype Choleraesuis with resistance to ciprofloxacin and ceftriaxone. Resistance to ciprofloxacin was related to nucleotide mutations in gyrA and parC, and resistance to ceftriaxone was related to the presence of CMY-2 beta -lactamase.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15655754     DOI： 10.1086/426593

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  7 in total

1.  Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.

Authors:  Hung-Jen Tang; Chi-Chung Chen; Chun-Cheng Zhang; Kuo Chen Cheng; Shyh-Ren Chiang; Yu-Hsin Chiu; Yee Huang Ku; Wen-Chien Ko; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

2.  Bacteraemia due to ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis in adult patients at a university hospital in Taiwan, 1996-2004.

Authors:  J-Y Wang; J-J Hwang; C-N Hsu; L-C Lin; P-R Hsueh
Journal:  Epidemiol Infect       Date:  2006-03-29       Impact factor: 2.451

3.  In vitro and in vivo intracellular killing effects of tigecycline against clinical nontyphoid Salmonella isolates using ceftriaxone as a comparator.

Authors:  Hung-Jen Tang; Wen-Chien Ko; Chi-Chung Chen; Po-Lin Chen; Han Siong Toh; Tzu Chieh Weng; Wen-Liang Yu; Shyh-Ren Chiang; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

4.  Fluoroquinolone-resistant Salmonella sp. in carcasses.

Authors:  Yu-Chih Wang; Kuang-Sheng Yeh; Chao-Chin Chang; Shih-Ling Hsuan; Ter-Hsin Chen
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

5.  Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan.

Authors:  Jing-Jou Yan; Chien-Shun Chiou; Tsai-Ling Yang Lauderdale; Shu-Huei Tsai; Jiunn-Jong Wu
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

6.  Antimicrobial Resistance and Molecular Investigation of H2S-Negative Salmonella enterica subsp. enterica serovar Choleraesuis Isolates in China.

Authors:  Jing Xie; Shengjie Yi; Jiangong Zhu; Peng Li; Beibei Liang; Hao Li; Xiaoxia Yang; Ligui Wang; Rongzhang Hao; Leili Jia; Zhihao Wu; Shaofu Qiu; Hongbin Song
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

7.  Molecular epidemiology and antimicrobial resistance of invasive non-typhoidal Salmonella in China, 2007-2016.

Authors:  Zeqiang Zhan; Xuebin Xu; Zhen Gu; Jianghong Meng; Xiayidan Wufuer; Mingliu Wang; Meilian Huang; Jianhui Chen; Chunmei Jing; Zhiying Xiong; Mei Zeng; Ming Liao; Jianmin Zhang
Journal:  Infect Drug Resist       Date:  2019-09-12       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.